Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent Read more about Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent
Bone Therapeutics, Cerhum, 3D-Side, mSKIL and IREC awarded €3M in BioWin supported funding to develop personalized, tissue engineered bone implants Read more about Bone Therapeutics, Cerhum, 3D-Side, mSKIL and IREC awarded €3M in BioWin supported funding to develop personalized, tissue engineered bone implants
Bone Therapeutics Provides Third Quarter 2020 Business Update Read more about Bone Therapeutics Provides Third Quarter 2020 Business Update
Bone Therapeutics and Catalent sign agreements to streamline production of the allogeneic cell therapy product, ALLOB Read more about Bone Therapeutics and Catalent sign agreements to streamline production of the allogeneic cell therapy product, ALLOB
Transparency notification received from S.R.I.W. SA and Sofipôle SA Read more about Transparency notification received from S.R.I.W. SA and Sofipôle SA
Bone Therapeutics: Information on the total number of voting rights and shares (October 2020) Read more about Bone Therapeutics: Information on the total number of voting rights and shares (October 2020)
Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study Read more about Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study
Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion Read more about Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion
Bone Therapeutics to present at 2020 Virtual Cell & Gene Meeting on the Mesa Read more about Bone Therapeutics to present at 2020 Virtual Cell & Gene Meeting on the Mesa
Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia Read more about Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia
